Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Halil Genc

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Diabetes Research and Clinical Practice|December 23, 2011
Elevated asymmetric dimethylarginine in plasma: an early marker for endothelial dysfunction in non-alcoholic fatty liver disease?Teoman Dogru, Halil Genc, Serkan Tapan, et al.
Scandinavian Journal of Gastroenterology|July 21, 2011
Circulating vaspin and its relationship with insulin sensitivity, adiponectin, and liver histology in subjects with non-alcoholic steatohepatitisHalil Genc, Teoman Dogru, Serkan Tapan, et al.
Clinical Endocrinology|June 9, 2012
Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver diseaseTeoman Dogru, Halil Genc, Serkan Tapan, et al.
Clinical Biochemistry|November 22, 2011
Soluble CD40 ligand, soluble P-selectin and von Willebrand factor levels in subjects with prediabetes: the impact of metabolic syndromeHalil Genc, Teoman Dogru, Serkan Tapan, et al.
Metabolic Syndrome and Related Disorders|May 27, 2015
Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver DiseaseCemal Nuri Ercin, Teoman Dogru, Halil Genc, et al.
Diabetes Research and Clinical Practice|September 8, 2006
Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose toleranceTeoman Dogru, Alper Sonmez, Ilker Tasci, et al.
Upsala Journal of Medical Sciences|August 25, 2010
Mean platelet volume and its relationship with carotid atherosclerosis in subjects with non-alcoholic fatty liver diseaseGuldem Kilciler, Halil Genc, Serkan Tapan, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|July 8, 2010
Circulating levels of interleukin-18 in patients with non-alcoholic fatty liver diseaseSerkan Tapan, Teoman Dogru, Muammer Kara, et al.
Metabolites|July 2, 2021
Betatrophin Levels Are Related to the Early Histological Findings in Nonalcoholic Fatty Liver DiseaseAlper Sonmez, Teoman Dogru, Cemal Nuri Ercin, et al.
Journal of Clinical Lipidology|August 1, 2015
Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver diseaseAlper Sonmez, Dragana Nikolic, Teoman Dogru, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Diabetes Research and Clinical Practice|December 23, 2011
Elevated asymmetric dimethylarginine in plasma: an early marker for endothelial dysfunction in non-alcoholic fatty liver disease?Teoman Dogru, Halil Genc, Serkan Tapan, et al.
Scandinavian Journal of Gastroenterology|July 21, 2011
Circulating vaspin and its relationship with insulin sensitivity, adiponectin, and liver histology in subjects with non-alcoholic steatohepatitisHalil Genc, Teoman Dogru, Serkan Tapan, et al.
Clinical Endocrinology|June 9, 2012
Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver diseaseTeoman Dogru, Halil Genc, Serkan Tapan, et al.
Clinical Biochemistry|November 22, 2011
Soluble CD40 ligand, soluble P-selectin and von Willebrand factor levels in subjects with prediabetes: the impact of metabolic syndromeHalil Genc, Teoman Dogru, Serkan Tapan, et al.
Metabolic Syndrome and Related Disorders|May 27, 2015
Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver DiseaseCemal Nuri Ercin, Teoman Dogru, Halil Genc, et al.
Diabetes Research and Clinical Practice|September 8, 2006
Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose toleranceTeoman Dogru, Alper Sonmez, Ilker Tasci, et al.
Upsala Journal of Medical Sciences|August 25, 2010
Mean platelet volume and its relationship with carotid atherosclerosis in subjects with non-alcoholic fatty liver diseaseGuldem Kilciler, Halil Genc, Serkan Tapan, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|July 8, 2010
Circulating levels of interleukin-18 in patients with non-alcoholic fatty liver diseaseSerkan Tapan, Teoman Dogru, Muammer Kara, et al.
Metabolites|July 2, 2021
Betatrophin Levels Are Related to the Early Histological Findings in Nonalcoholic Fatty Liver DiseaseAlper Sonmez, Teoman Dogru, Cemal Nuri Ercin, et al.
Journal of Clinical Lipidology|August 1, 2015
Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver diseaseAlper Sonmez, Dragana Nikolic, Teoman Dogru, et al.
Pageof 3